SUZANNA CARLTON: Open Payments
NPI 1336695584 · SHELBYVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,788 in 90 payments from 14 companies in 2025. Trend: 2023 $763 · 2024 $1,358 · 2025 $1,788
Food & beverage: $1,788
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $514 |
| Novartis Pharmaceuticals Corporation | 28 | $391 |
| Amgen Inc. | 14 | $231 |
| AstraZeneca Pharmaceuticals LP | 12 | $203 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $92 |
| Corcept Therapeutics | 3 | $63 |
| BridgeBio Pharma, Inc. | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $37 |
Products named: LEQVIO, Wegovy, FARXIGA, JARDIANCE, REPATHA, Ozempic, Korlym, Attruby.
Industry payments across IN — which companies pay providers there.
